An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes

Abstract

Antiepileptic drugs (AEDs) are prescribed commonly to women of childbearing age. In utero exposure to some AEDs can have significant cognitive and behavioral consequences for the unborn child. Recently, prospective studies of women taking AEDs during pregnancy have added significantly to our understanding of cognitive and behavioral teratogenic risks posed by fetal AED exposure. Valproate is clearly associated with impaired cognitive development as well as an increased risk of disorders such as autism and autism spectrum disorder. Exposure to carbamazepine, lamotrigine, levetiracetam, or phenytoin monotherapy is associated with more favorable cognitive and behavioral outcomes than valproate, but more data are required to clarify if these AEDs have more subtle effects on cognition and behavior. There are insufficient data on the developmental effects of other AEDs in humans. Further, the underlying mechanisms of cognitive teratogenesis are poorly understood, including the genetic factors that affect susceptibility to AEDs.

Keywords

epilepsy - pregnancy - mood disorder - antiepileptic - valproic acid - lamotrigine - levetiracetam - neurodevelopment

• References

• 1 Bobo WV, Davis RL, Toh S , et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol 2012; 26 (6) 578-588
• 2 Edey S, Moran N, Nashef L. SUDEP and epilepsy-related mortality in pregnancy. Epilepsia 2014; 55 (7) e72-e74
• 3 Viguera AC, Whitfield T, Baldessarini RJ , et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164 (12) 1817-1824 , quiz 1923
• 4 Hernández-Díaz S, Smith CR, Shen A , et al; North American AED Pregnancy Registry; North American AED Pregnancy Registry. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012; 78 (21) 1692-1699
• 5 Mawhinney E, Craig J, Morrow J , et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013; 80 (4) 400-405
• 6 Campbell E, Kennedy F, Russell A , et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 2014; 85 (9) 1029-1034
• 7 Vajda FJ, O'Brien TJ, Lander CM, Graham J, Eadie MJ. The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130 (4) 234-238
• 8 Harden CL. Pregnancy and epilepsy. Continuum (Minneap Minn) 2014; 20 (1 Neurology of Pregnancy‰: 60-79
• 9 Margulis AV, Mitchell AA, Gilboa SM , et al; National Birth Defects Prevention Study. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012; 207 (5) 405.e1-405.e7
• 10 Mines D, Tennis P, Curkendall SM , et al. Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf 2014; 23 (10) 1017-1025
• 11 Nadebaum C, Anderson V, Vajda F, Reutens D, Wood A. Neurobehavioral consequences of prenatal antiepileptic drug exposure. Dev Neuropsychol 2012; 37 (1) 1-29
• 12 Veiby G, Daltveit AK, Schjølberg S , et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013; 54 (8) 1462-1472
• 13 Banach R, Boskovic R, Einarson T, Koren G. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug Saf 2010; 33 (1) 73-79
• 14 Christensen J, Grønborg TK, Sørensen MJ , et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309 (16) 1696-1703
• 15 Adab N, Kini U, Vinten J , et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75 (11) 1575-1583
• 16 Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76 (8) 719-726
• 17 Baker GA, Bromley RL, Briggs M , et al; Liverpool and Manchester Neurodevelopment Group. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84 (4) 382-390
• 18 Shallcross R, Bromley RL, Cheyne CP , et al; Liverpool and Manchester Neurodevelopment Group; UK Epilepsy and Pregnancy Register. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology 2014; 82 (3) 213-221
• 19 Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008; 13 (1) 229-236
• 20 Meador KJ, Baker GA, Browning N , et al; NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013; 12 (3) 244-252
• 21 Gaily E, Kantola-Sorsa E, Hiilesmaa V , et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62 (1) 28-32
• 22 Meador KJ, Baker GA, Browning N , et al; NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360 (16) 1597-1605
• 23 Meador KJ, Baker GA, Browning N , et al. Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav 2011; 21 (2) 147-152
• 24 Cohen MJ, Meador KJ, Browning N , et al. Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav 2011; 22 (2) 240-246
• 25 Meador KJ, Baker GA, Browning N , et al; NEAD Study Group. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology 2012; 78 (16) 1207-1214
• 26 Cohen MJ, Meador KJ, Browning N , et al; NEAD study group. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav 2013; 29 (2) 308-315
• 27 Bromley RL, Mawer G, Love J , et al; Liverpool and Manchester Neurodevelopment Group [LMNDG]. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51 (10) 2058-2065
• 28 Bromley RL, Mawer GE, Briggs M , et al; Liverpool and Manchester Neurodevelopment Group. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013; 84 (6) 637-643
• 29 Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A. The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011; 17 (1) 133-142
• 30 Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA ; Liverpool Manchester Neurodevelopment Group; UK Epilepsy and Pregnancy Register. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011; 76 (4) 383-389
• 31 Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002; 39 (4) 251-259
• 32 Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA ; Liverpool and Manchester Neurodevelopment Study Group. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64 (6) 949-954
• 33 Eriksson K, Viinikainen K, Mönkkönen A , et al. Children exposed to valproate in utero—population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005; 65 (3) 189-200
• 34 Mawer G, Clayton-Smith J, Coyle H, Kini U. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 2002; 11 (8) 512-518
• 35 McVearry KM, Gaillard WD, VanMeter J, Meador KJ. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav 2009; 16 (4) 609-616
• 36 Thomas SV, Sukumaran S, Lukose N, George A, Sarma PS. Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007; 48 (12) 2234-2240
• 37 Sattler J. Assessment of Children. 3rd ed. San Diego, CA: Jerome M. Sattler Pub., Inc; 1992
• 38 Christianson AL, Chesler N, Kromberg JG. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 1994; 36 (4) 361-369
• 39 Williams PG, Hersh JH. A male with fetal valproate syndrome and autism. Dev Med Child Neurol 1997; 39 (9) 632-634
• 40 Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43 (3) 202-206
• 41 Rasalam AD, Hailey H, Williams JH , et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005; 47 (8) 551-555
• 42 Vinten J, Bromley RL, Taylor J, Adab N, Kini U, Baker GA ; Liverpool and Manchester Neurodevelopment Group. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009; 14 (1) 197-201
• 43 Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2006. Vital Health Stat 10 2007; (234) 1-79
• 44 Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001; 70 (1) 15-21
• 45 Scolnik D, Nulman I, Rovet J , et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271 (10) 767-770
• 46 van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol 1991; 164 (1 Pt 1) 121-128
• 47 Wide K, Winbladh B, Tomson T, Sars-Zimmer K, Berggren E. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev Med Child Neurol 2000; 42 (2) 87-92
• 48 Wide K, Henning E, Tomson T, Winbladh B. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 2002; 91 (4) 409-414
• 49 Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996; 75 (6) 517-520
• 50 Rovet J, Cole S, Nulman I, Scolnik D, Altmann D, Koren G. Effects of maternal epilepsy on children's neurodevelopment. Child Neuropsychol 1995; 1 (2) 150-157
• 51 Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011; 96 (7) 643-647
• 52 Rihtman T, Parush S, Ornoy A. Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function. Reprod Toxicol 2013; 41: 115-125
• 53 Manthey D, Asimiadou S, Stefovska V , et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005; 193 (2) 497-503
• 54 Kim J, Kondratyev A, Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther 2007; 323 (1) 165-173
• 55 Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274 (19) 1518-1525
• 56 Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van De Poll NE, Boer K. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr 2000; 89 (5) 533-541
• 57 Hill RM, Verniaud WM, Rettig GM, Tennyson LM, Craig JP. Relation between antiepileptic drug exposure of the infant and developmental potential. In: Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, , eds. Epilepsy, Pregnancy and the Child. New York, NY: Raven Press; 1982: 409-417
• 58 Koch S, Titze K, Zimmermann RB, Schröder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999; 40 (9) 1237-1243
• 59 Loring DW, Meador KJ, Thompson WO. Neurodevelopment after in utero exposure to phenytoin and carbamazepine. JAMA 1994; 272 (11) 850-851
• 60 Rihtman T, Parush S, Ornoy A. Preliminary findings of the developmental effects of in utero exposure to topiramate. Reprod Toxicol 2012; 34 (3) 308-311
• 61 Lacosamide Prescribing Information Available at: http://www.vimpat.com/pdf/vimpat_PI.pdf . Accessed October 1, 2014
• 62 Veiby G, Engelsen BA, Gilhus NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol 2013; 70 (11) 1367-1374
• 63 Gaily E, Kantola-Sorsa E, Granström ML. Intelligence of children of epileptic mothers. J Pediatr 1988; 113 (4) 677-684
• 64 Bath KG, Scharfman HE. Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research. Epilepsy Behav 2013; 26 (3) 427-439
• 65 Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism—a current review of clinical and animal studies. Neurotoxicol Teratol 2013; 36: 47-56
• 66 Manent JB, Jorquera I, Mazzucchelli I , et al. Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. Epilepsia 2007; 48 (4) 684-693
• 67 Manent JB, Jorquera I, Franco V, Ben-Ari Y, Perucca E, Represa A. Antiepileptic drugs and brain maturation: fetal exposure to lamotrigine generates cortical malformations in rats. Epilepsy Res 2008; 78 (2-3) 131-139
• 68 Miyazaki K, Narita N, Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int J Dev Neurosci 2005; 23 (2-3) 287-297
• 69 Stefovska VG, Uckermann O, Czuczwar M , et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008; 64 (4) 434-445
• 70 Chen J, Cai F, Cao J, Zhang X, Li S. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res 2009; 87 (13) 2898-2907
• 71 Shi XY, Wang JW, Cui H, Li BM, Lei GF, Sun RP. Effects of antiepileptic drugs on mRNA levels of BDNF and NT-3 and cell neogenesis in the developing rat brain. Brain Dev 2010; 32 (3) 229-235
• 72 Umka J, Mustafa S, ElBeltagy M , et al. Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010; 166 (1) 15-22
• 73 Sabers A, Bertelsen FC, Scheel-Krüger J, Nyengaard JR, Møller A. Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism. Neurosci Lett 2014; 580: 12-16
• 74 Bittigau P, Sifringer M, Genz K , et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002; 99 (23) 15089-15094
• 75 Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 2003; 993: 103-114 , discussion 123–124
• 76 Forcelli PA, Kim J, Kondratyev A, Gale K. Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain. Epilepsia 2011; 52 (12) e207-e211
• 77 Ogura H, Yasuda M, Nakamura S, Yamashita H, Mikoshiba K, Ohmori H. Neurotoxic damage of granule cells in the dentate gyrus and the cerebellum and cognitive deficit following neonatal administration of phenytoin in mice. J Neuropathol Exp Neurol 2002; 61 (11) 956-967
• 78 Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004; 187 (2) 403-409
• 79 Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48 (Suppl. 05) 19-26
• 80 Katz I, Kim J, Gale K, Kondratyev A. Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 2007; 322 (2) 494-500
• 81 Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A 2007; 104 (33) 13501-13506
• 82 Rinaldi T, Silberberg G, Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008; 18 (4) 763-770
• 83 Sui L, Chen M. Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories. Brain Res Bull 2012; 87 (6) 556-563
• 84 Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol 2012; 72 (3) 363-372
• 85 Ikonomidou C, Scheer I, Wilhelm T , et al. Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol 2007; 11 (5) 297-301
• 86 Wood AG, Chen J, Barton S , et al. Altered cortical thickness following prenatal sodium valproate exposure. Ann Clin Transl Neurol 2014; 1 (7) 497-501
• 87 Ikonomidou C, Bittigau P, Ishimaru MJ , et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287 (5455) 1056-1060
• 88 Wang C, Luan Z, Yang Y, Wang Z, Cui Y, Gu G. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes. Neurosci Lett 2011; 497 (2) 122-127
• 89 Hansen HH, Krutz B, Sifringer M , et al. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann Neurol 2008; 64 (1) 42-52
• 90 Aluru N, Deak KL, Jenny MJ, Hahn ME. Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish. Neurotoxicol Teratol 2013; 40: 46-58
• 91 Cohen OS, Varlinskaya EI, Wilson CA, Glatt SJ, Mooney SM. Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Int J Dev Neurosci 2013; 31 (8) 740-750
• 92 Lee Y, Kim YH, Yun JS, Lee CJ. Valproic acid decreases the proliferation of telencephalic cells in zebrafish larvae. Neurotoxicol Teratol 2013; 39: 91-99
• 93 Göttlicher M, Minucci S, Zhu P , et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001; 20 (24) 6969-6978
• 94 Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276 (39) 36734-36741
• 95 Fujiki R, Sato A, Fujitani M, Yamashita T. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons. Cell Death Dis 2013; 4: e677
• 96 Dong E, Chen Y, Gavin DP, Grayson DR, Guidotti A. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 2010; 5 (8) 730-735
• 97 Emes RD, Clifford H, Haworth KE , et al. Antiepileptic drugs and the fetal epigenome. Epilepsia 2013; 54 (1) e16-e19
• 98 Smith AK, Conneely KN, Newport DJ , et al. Prenatal antiepileptic exposure associates with neonatal DNA methylation differences. Epigenetics 2012; 7 (5) 458-463
• 99 Dean J, Robertson Z, Reid V , et al. Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am J Med Genet A 2007; 143A (19) 2303-2311
• 100 Di Rosa G, Lenzo P, Parisi E , et al. Role of plasma homocysteine levels and MTHFR polymorphisms on IQ scores in children and young adults with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2013; 29 (3) 548-551
• 101 Alonso-Aperte E, Ubeda N, Achón M, Pérez-Miguelsanz J, Varela-Moreiras G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 1999; 52 (4) 750-756
• 102 Hishida R, Ellerbeck U, Schmahl H, Ehlers K, Nau H. Valproate and folate alter homocysteine and methionine metabolism in pregnant mice. 23rd Annual Conference of the European Teratology Society. University College Dublin, Ireland. Teratology 1995; 51 (6) 24A-25A
• 103 Wilson RD, Davies G, Désilets V , et al; Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003; 25 (11) 959-973
• 104 Kjaer D, Horvath-Puhó E, Christensen J , et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG 2008; 115 (1) 98-103
• 105 Aguglia U, Barboni G, Battino D , et al. Italian consensus conference on epilepsy and pregnancy, labor and puerperium. Epilepsia 2009; 50 (Suppl. 01) 7-23
• 106 Blencowe H, Cousens S, Modell B, Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010; 39 (Suppl. 01) i110-i121
• 107 Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003; 60 (4) 575-579
• 108 Harden CL, Pennell PB, Koppel BS , et al; American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73 (2) 142-149
• 109 Chatzi L, Papadopoulou E, Koutra K , et al. Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort ‘Rhea’ study in Crete, Greece. Public Health Nutr 2012; 15 (9) 1728-1736
• 110 Roth C, Magnus P, Schjølberg S , et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA 2011; 306 (14) 1566-1573
• 111 Surén P, Roth C, Bresnahan M , et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 2013; 309 (6) 570-577
• 112 Schmidt RJ, Tancredi DJ, Ozonoff S , et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 2012; 96 (1) 80-89
• 113 Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med 2009; 4 (Suppl. 01) S17-S30
• 114 Quigley MA, Hockley C, Carson C, Kelly Y, Renfrew MJ, Sacker A. Breastfeeding is associated with improved child cognitive development: a population-based cohort study. J Pediatr 2012; 160 (1) 25-32
• 115 Kramer MS, Aboud F, Mironova E , et al; Promotion of Breastfeeding Intervention Trial (PROBIT) Study Group. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry 2008; 65 (5) 578-584
• 116 Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 2013; 29 (1) 13-18
• 117 Davis AR, Pack AM, Kritzer J, Yoon A, Camus A. Reproductive history, sexual behavior and use of contraception in women with epilepsy. Contraception 2008; 77 (6) 405-409
• 118 Gaffield ME, Culwell KR, Lee CR. The use of hormonal contraception among women taking anticonvulsant therapy. Contraception 2011; 83 (1) 16-29